163 related articles for article (PubMed ID: 29154799)
1. Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction.
van Breda SGJ; Claessen SMH; van Herwijnen M; Theunissen DHJ; Jennen DGJ; de Kok TMCM; Kleinjans JCS
Toxicology; 2018 Jan; 393():160-170. PubMed ID: 29154799
[TBL] [Abstract][Full Text] [Related]
2. Nuclear and Mitochondrial DNA Methylation Patterns Induced by Valproic Acid in Human Hepatocytes.
Wolters JEJ; van Breda SGJ; Caiment F; Claessen SM; de Kok TMCM; Kleinjans JCS
Chem Res Toxicol; 2017 Oct; 30(10):1847-1854. PubMed ID: 28853863
[TBL] [Abstract][Full Text] [Related]
3. Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis.
Wolters JE; van Herwijnen MH; Theunissen DH; Jennen DG; Van den Hof WF; de Kok TM; Schaap FG; van Breda SG; Kleinjans JC
Chem Res Toxicol; 2016 Dec; 29(12):2164-2174. PubMed ID: 27989131
[TBL] [Abstract][Full Text] [Related]
4. Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes.
Wolters JEJ; van Breda SGJ; Grossmann J; Fortes C; Caiment F; Kleinjans JCS
Toxicol Lett; 2018 Jun; 289():1-13. PubMed ID: 29501571
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid promotes mitochondrial dysfunction in primary human hepatocytes in vitro; impact of C/EBPα-controlled gene expression.
Caiment F; Wolters J; Smit E; Schrooders Y; Kleinjans J; van den Beucken T
Arch Toxicol; 2020 Oct; 94(10):3463-3473. PubMed ID: 32623605
[TBL] [Abstract][Full Text] [Related]
6. Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
Chang R; Chou MC; Hung LY; Wang ME; Hsu MC; Chiu CH
Biomed Res Int; 2016; 2016():9576503. PubMed ID: 27034954
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells.
Rodrigues RM; Branson S; De Boe V; Sachinidis A; Rogiers V; De Kock J; Vanhaecke T
Arch Toxicol; 2016 Mar; 90(3):677-89. PubMed ID: 25716160
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models.
Vitins AP; Kienhuis AS; Speksnijder EN; Roodbergen M; Luijten M; van der Ven LT
Arch Toxicol; 2014 Aug; 88(8):1573-88. PubMed ID: 24535564
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes.
Surendradoss J; Chang TK; Abbott FS
Toxicol Appl Pharmacol; 2012 Nov; 264(3):413-22. PubMed ID: 22940460
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
Ma L; Wang Y; Chen X; Zhao L; Guo Y
Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles of murine fatty liver induced by the administration of valproic acid.
Lee MH; Hong I; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2007 Apr; 220(1):45-59. PubMed ID: 17292431
[TBL] [Abstract][Full Text] [Related]
12. Data on novel DNA methylation changes induced by valproic acid in human hepatocytes.
Wolters J; van Breda S; Claessen S; de Kok T; Kleinjans J
Data Brief; 2018 Feb; 16():161-171. PubMed ID: 29201983
[TBL] [Abstract][Full Text] [Related]
13. Role of oxidative metabolism in the effect of valproic acid on markers of cell viability, necrosis, and oxidative stress in sandwich-cultured rat hepatocytes.
Kiang TK; Teng XW; Karagiozov S; Surendradoss J; Chang TK; Abbott FS
Toxicol Sci; 2010 Dec; 118(2):501-9. PubMed ID: 20861068
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in situ generated valproyl 1-O-β-acyl glucuronide in valproic acid toxicity in sandwich-cultured rat hepatocytes.
Surendradoss J; Chang TK; Abbott FS
Drug Metab Dispos; 2014 Nov; 42(11):1834-42. PubMed ID: 25147275
[TBL] [Abstract][Full Text] [Related]
15. Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.
Elphick LM; Pawolleck N; Guschina IA; Chaieb L; Eikel D; Nau H; Harwood JL; Plant NJ; Williams RS
Dis Model Mech; 2012 Mar; 5(2):231-40. PubMed ID: 22003123
[TBL] [Abstract][Full Text] [Related]
16. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
[TBL] [Abstract][Full Text] [Related]
17. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
Van den Hof WF; Van Summeren A; Lommen A; Coonen ML; Brauers K; van Herwijnen M; Wodzig WK; Kleinjans JC
Toxicology; 2014 Oct; 324():18-26. PubMed ID: 25047351
[TBL] [Abstract][Full Text] [Related]
18. Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis.
Goda K; Saito K; Muta K; Kobayashi A; Saito Y; Sugai S
J Toxicol Sci; 2018; 43(6):395-405. PubMed ID: 29877216
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
Tong V; Teng XW; Chang TK; Abbott FS
Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
[TBL] [Abstract][Full Text] [Related]
20. Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence.
Pirozzi C; Lama A; Annunziata C; Cavaliere G; De Caro C; Citraro R; Russo E; Tallarico M; Iannone M; Ferrante MC; Mollica MP; Mattace Raso G; De Sarro G; Calignano A; Meli R
FASEB J; 2020 Jan; 34(1):676-690. PubMed ID: 31914696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
